22nd Century Group Inc

22nd Century Group Inc (XXII) Stock Analysis

$1.550

-0.305 (-19.69%)At close

Loading chart…
High
1.760
Open
1.730
VWAP
1.61
Volume
219.52K
Mkt Cap
6.51M
Low
1.510
Amount
352.70K
EV/EBITDA, TTM
0.00

22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.

AI analysis of 22nd Century Group Inc (XXII)

Sell

Currently, 22nd Century Group Inc (XXII) is not a good buy. The stock has dropped 99.99% year-to-date and 61.60% in the last five days, indicating severe volatility and investor loss. The RSI is extremely low at 7.524, suggesting the stock is oversold, but this could also indicate a lack of buying interest. With a forward P/E ratio of 0 and a gross margin of -10.23%, the company is struggling financially. The main risk is the upcoming earnings report on November 16, which is expected to lead to a further price drop of approximately 34.82%.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 1.55
Low
—
Average
—
High
—

Roth MKM

2023-08-23

Price Target

$80

Strong Buy

Alliance Global Partners

2023-08-17

Price Target

—

Hold

TD Cowen

2023-08-15

Price Target

$40

Hold

Dawson James

2023-08-15

Price Target

$7.5

Strong Buy

Dawson James

2023-07-03

Price Target

$16

Strong Buy

Valuation Metrics

The current forward P/E ratio for 22nd Century Group Inc (XXII) is 0.00, compared to its 5-year average forward P/E of -8.84.

Forward P/E

Fair
5Y Average P/E
-8.84
Current P/E
0.00
Overvalued
21.47
Undervalued
-39.15

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
-3.49
Current EV/EBITDA
0.00
Overvalued
-0.67
Undervalued
-6.31

Forward P/S

Fair
5Y Average P/S
1.83
Current P/S
0.00
Overvalued
4.04
Undervalued
-0.39

Events Timeline

2026-11-04 (ET)

20:00:00

22nd Century Trading Halted, News Pending

2026-10-28 (ET)

17:01:00

22nd Century Expands Pinnacle Brand to 13 States

2026-10-22 (ET)

11:00:00

Company Expects Q3 Net Loss of $2.6M

2026-06-12 (ET)

17:30:00

22nd Century Files to Sell 3.02M Shares of Common Stock

2026-06-11 (ET)

20:00:00

22nd Century Trading Halted, News Pending

News

XXII FAQ — answered by Alphio AI

22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It operates in the Consumer Non-Cyclicals sector (CIGARETTES industry).

Currently, 22nd Century Group Inc (XXII) is not a good buy. The stock has dropped 99.99% year-to-date and 61.60% in the last five days, indicating severe volatility and investor loss. The RSI is extremely low at 7.524, suggesting the stock is oversold, but this could also indicate a lack of buying interest. With a forward P/E ratio of 0 and a gross margin of -10.23%, the company is struggling financially. The main risk is the upcoming earnings report on November 16, which is expected to lead to a further price drop of approximately 34.82%.

1 analysts cover XXII: 1 rate it Buy, 0 Hold and 0 Sell.

Community

More ↗
Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading